LCN2 and chronic kidney disease: Here, for the first time, we examined the concentration of KIM-1 and NGAL at different time points during disease progression in IRI mouse models to evaluate whether these two tubular biomarkers could provide a dynamic monitoring of AKI-to-CKD progression.